Cancer Control (Sep 2022)

Differences in Hospital, Emergency Room and Outpatient Visits Among Adults With and Without Monoclonal Gammopathy of Undetermined Significance

  • Maira A. Castañeda-Avila PhD,
  • Kate L. Lapane PhD,
  • Sharina D. Person PhD,
  • Bill M. Jesdale PhD,
  • Yanhua Zhou MS,
  • Kathleen M. Mazor EdD,
  • Mara M. Epstein ScD

DOI
https://doi.org/10.1177/10732748221126936
Journal volume & issue
Vol. 29

Abstract

Read online

Introduction This study evaluated the impact of receiving a monoclonal gammopathy of undetermined significance (MGUS) diagnosis on healthcare utilization from patients at a community-based multispecialty provider organization. Methods A cohort of patients with MGUS (n = 429) were matched on sex, age, and length of enrollment to a cohort of patients without MGUS (n = 1286). Healthcare utilization was assessed: 1-12 months before, 1 month before and after, and 1-12 months after diagnosis/index date. Multivariable conditional Poisson models compared change in utilization of each service in patients with and without MGUS. Results During the 2 months around diagnosis/index date, the rates of emergency room, hospital and outpatient visits were higher for patients with MGUS than patients without MGUS. In the year before MGUS diagnosis, the association was still elevated, although attenuated. Conclusion Understanding the care of MGUS patients is important given that multiple myeloma patients with a pre-existing MGUS diagnosis may have a better prognosis.